Stay updated on Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision label 'Revision: v3.4.2' was added, and the notice about government funding lapses was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page adds a government funding lapse notice and NIH/OPM status update, and updates the revision to v3.4.1 (replacing the previous v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary toggle, updates and standardizes QC-related labels (Last Update Submitted that Met QC Criteria) and capitalization (No FEAR Act Data), and shows a new revision version (v3.4.0), while removing the older QC label and older revision reference.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a new revision entry 'Revision: v3.3.4' in the update history, replacing the prior 'Revision: v3.3.3'. This update pertains to version history and does not modify study details or criteria.SummaryDifference0.1%

- Check63 days agoChange DetectedIntroduced a dedicated Locations section highlighting Colorado sites; the Colorado Locations header was removed and location information was reorganized.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.